Digest Network Come funziona
Network
/
Società
No
Non verificato

Novocure

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieOncologiaSalute

43 comunicati stampa

Guarda tutti i comunicati
12/01/2026
Oncologia
Salute
Igiene alimentare
Medicina - Varie
Farmaceutica
Biotecnologia
Web e Social Network
Telefonia e Varie
Mercato azionario
Eventi
Finanza
Novocure Announces Preliminary Full Year and Fourth Quarter 2025 Performance and Provides Company Update
Fonte
Novocure
Emittente
Business Wire
1.00
0
22/12/2025
Sanità
Attrezzature medico-sanitarie
Salute
Medicina - Varie
Oncologia
Web e Social Network
Telefonia e Varie
Finanza
Fiere
Novocure to Present at 44th Annual J.P. Morgan Healthcare Conference
Fonte
Novocure
Emittente
Business Wire
1.00
0
01/12/2025
Mercato del lavoro
Salute
Oncologia
Attrezzature medico-sanitarie
Novocure Appoints Company President Frank Leonard as Chief Executive Officer
Fonte
Novocure
Emittente
Business Wire
1.00
0
26/11/2025
Eventi
Web e Social Network
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Oncologia
Novocure to Participate in 37th Annual Piper Sandler Healthcare Conference
Fonte
Novocure
Emittente
Business Wire
1.00
0
12/11/2025
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Oncologia
Eventi
Web e Social Network
Novocure to Participate in 2025 Jefferies Global Healthcare Conference
Fonte
Novocure
Emittente
Business Wire
1.00
0
30/10/2025
Oncologia
Attrezzature medico-sanitarie
Salute
Medicina - Varie
Farmaceutica
Biotecnologia
Web e Social Network
Telefonia e Varie
Mercato azionario
Novocure Reports Third Quarter 2025 Financial Results
Fonte
Novocure
Emittente
Business Wire
1.00
0
15/10/2025
Oncologia
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Eventi
Fiere
Industria
Novocure to Present New Research for Tumor Treating Fields (TTFields) Therapy at European Association of Neuro-Oncology (EANO) Meeting and the European Society for Medical Oncology (ESMO) Congress
Fonte
Novocure
Emittente
Business Wire
1.00
0
01/10/2025
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Oncologia
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Novocure to Report Third Quarter 2025 Financial Results
Fonte
Novocure
Emittente
Business Wire
1.00
0
29/09/2025
Medicina nucleare
Biotecnologia
Farmaceutica
Medicina - Varie
Oncologia
Salute
Eventi
Novocure to Present Final Results from the Pivotal Phase 3 METIS Trial of its Tumor Treating Fields (TTFields) Therapy for Brain Metastases from Non-Small Cell Lung Cancer at 2025 ASTRO Annual Meeting
Fonte
Novocure
Emittente
Business Wire
1.00
0
15/09/2025
Industria
Tecnica
Attrezzature medico-sanitarie
Medicina - Varie
Biotecnologia
Salute
Farmaceutica
Oncologia
Novocure’s Optune Lua® Receives Approval in Japan for the Treatment of Unresectable Advanced/Recurrent Non-Small Cell Lung Cancer (NSCLC)
Fonte
Novocure
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0